178 related articles for article (PubMed ID: 23860260)
41. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
42. Sox6 directly silences epsilon globin expression in definitive erythropoiesis.
Yi Z; Cohen-Barak O; Hagiwara N; Kingsley PD; Fuchs DA; Erickson DT; Epner EM; Palis J; Brilliant MH
PLoS Genet; 2006 Feb; 2(2):e14. PubMed ID: 16462943
[TBL] [Abstract][Full Text] [Related]
43. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site.
Grogan SP; Olee T; Hiraoka K; Lotz MK
Arthritis Rheum; 2008 Sep; 58(9):2754-63. PubMed ID: 18759300
[TBL] [Abstract][Full Text] [Related]
44. Identification of a nuclear factor-I family protein-binding site in the silencer region of the cartilage matrix protein gene.
Szabó P; Moitra J; Rencendorj A; Rákhely G; Rauch T; Kiss I
J Biol Chem; 1995 Apr; 270(17):10212-21. PubMed ID: 7730325
[TBL] [Abstract][Full Text] [Related]
45. Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.
Pérez-Casellas LA; Wang X; Howard KD; Rehage MW; Strong DD; Linkhart TA
Biochim Biophys Acta; 2009 Feb; 1789(2):78-87. PubMed ID: 18809517
[TBL] [Abstract][Full Text] [Related]
46. SOX9 is dispensable for the initiation of epigenetic remodeling and the activation of marker genes at the onset of chondrogenesis.
Liu CF; Angelozzi M; Haseeb A; Lefebvre V
Development; 2018 Jul; 145(14):. PubMed ID: 30021842
[TBL] [Abstract][Full Text] [Related]
47. Distinct roles of Sox5, Sox6, and Sox9 in different stages of chondrogenic differentiation.
Ikeda T; Kawaguchi H; Kamekura S; Ogata N; Mori Y; Nakamura K; Ikegawa S; Chung UI
J Bone Miner Metab; 2005; 23(5):337-40. PubMed ID: 16133682
[No Abstract] [Full Text] [Related]
48. Identification and characterization of the human long form of Sox5 (L-SOX5) gene.
Ikeda T; Zhang J; Chano T; Mabuchi A; Fukuda A; Kawaguchi H; Nakamura K; Ikegawa S
Gene; 2002 Sep; 298(1):59-68. PubMed ID: 12406576
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9.
Tsuda M; Takahashi S; Takahashi Y; Asahara H
J Biol Chem; 2003 Jul; 278(29):27224-9. PubMed ID: 12732631
[TBL] [Abstract][Full Text] [Related]
50. Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.
Yamagiwa H; Yamada Y; Bolander ME; Sarkar G
Mol Biotechnol; 2004 Sep; 28(1):1-8. PubMed ID: 15456958
[TBL] [Abstract][Full Text] [Related]
51. SOX9cre1, a cis-acting regulatory element located 1.1 Mb upstream of SOX9, mediates its enhancement through the SHH pathway.
Bien-Willner GA; Stankiewicz P; Lupski JR
Hum Mol Genet; 2007 May; 16(10):1143-56. PubMed ID: 17409199
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells.
Rich JT; Rosová I; Nolta JA; Myckatyn TM; Sandell LJ; McAlinden A
Biochem Biophys Res Commun; 2008 Jul; 372(1):230-5. PubMed ID: 18482578
[TBL] [Abstract][Full Text] [Related]
53. Functional gene screening system identified TRPV4 as a regulator of chondrogenic differentiation.
Muramatsu S; Wakabayashi M; Ohno T; Amano K; Ooishi R; Sugahara T; Shiojiri S; Tashiro K; Suzuki Y; Nishimura R; Kuhara S; Sugano S; Yoneda T; Matsuda A
J Biol Chem; 2007 Nov; 282(44):32158-67. PubMed ID: 17804410
[TBL] [Abstract][Full Text] [Related]
54. Enhanced Calvarial Bone Repair Using ASCs Engineered with RNA-Guided Split dCas12a System that Co-Activates Sox 5, Sox6, and Long Non-Coding RNA H19.
Nguyen NTK; Lee SS; Chen PH; Chang YH; Pham NN; Chang CW; Pham DH; Ngo DKT; Dang QT; Truong VA; Truong VA; Chang YH; Hu YC
Small; 2024 May; 20(21):e2306612. PubMed ID: 38126683
[TBL] [Abstract][Full Text] [Related]
55. Combinatorial CRISPR/Cas9 Approach to Elucidate a Far-Upstream Enhancer Complex for Tissue-Specific Sox9 Expression.
Mochizuki Y; Chiba T; Kataoka K; Yamashita S; Sato T; Kato T; Takahashi K; Miyamoto T; Kitazawa M; Hatta T; Natsume T; Takai S; Asahara H
Dev Cell; 2018 Sep; 46(6):794-806.e6. PubMed ID: 30146478
[TBL] [Abstract][Full Text] [Related]
56. Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation.
Lengner CJ; Hassan MQ; Serra RW; Lepper C; van Wijnen AJ; Stein JL; Lian JB; Stein GS
J Biol Chem; 2005 Apr; 280(16):15872-9. PubMed ID: 15703179
[TBL] [Abstract][Full Text] [Related]
57. Rac1 signaling stimulates N-cadherin expression, mesenchymal condensation, and chondrogenesis.
Woods A; Wang G; Dupuis H; Shao Z; Beier F
J Biol Chem; 2007 Aug; 282(32):23500-8. PubMed ID: 17573353
[TBL] [Abstract][Full Text] [Related]
58. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6.
Sekiya I; Tsuji K; Koopman P; Watanabe H; Yamada Y; Shinomiya K; Nifuji A; Noda M
J Biol Chem; 2000 Apr; 275(15):10738-44. PubMed ID: 10753864
[TBL] [Abstract][Full Text] [Related]
59. SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter.
Murakami A; Ishida S; Thurlow J; Revest JM; Dickson C
Nucleic Acids Res; 2001 Aug; 29(16):3347-55. PubMed ID: 11504872
[TBL] [Abstract][Full Text] [Related]
60. Chromatin profiling identifies chondrocyte-specific Sox9 enhancers important for skeletal development.
Ichiyama-Kobayashi S; Hata K; Wakamori K; Takahata Y; Murakami T; Yamanaka H; Takano H; Yao R; Uzawa N; Nishimura R
JCI Insight; 2024 Jun; 9(11):. PubMed ID: 38855864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
